{"id":"W3137618571","doi":"10.1007/s00280-021-04249-7","title":"Niraparib with androgen receptor-axis-targeted therapy in patients with metastatic castration-resistant prostate cancer: safety and pharmacokinetic results from a phase 1b study (BEDIVERE)","year":2021,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Janssen Research and Development","keywords":"Medicine; Prostate cancer; Abiraterone acetate; Internal medicine; Prednisone; Enzalutamide; Adverse effect; Oncology; Pharmacokinetics; Urology; Discontinuation; Androgen receptor; Cancer; Androgen deprivation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002524445,0.000838013,0.001425874,0.0002564002,0.0002424433,0.0008425404,0.0006528302,0.0005636034,0.001217975],"category_scores_gemma":[0.001395244,0.0004397245,0.000974995,0.0003264261,0.0005333272,0.0005494059,0.0003418853,0.001766103,0.0003295251],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006172007,"about_ca_system_score_gemma":0.00100038,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005242315,"about_ca_topic_score_gemma":0.001414408,"domain_scores_codex":[0.9989385,0.0006239448,0.00005722934,0.0001379591,0.0001605879,0.00008161903],"domain_scores_gemma":[0.9991067,0.0001666853,0.0002665354,0.00009818426,0.00008110479,0.0002807571],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4319949,0.09317569,0.04278852,0.001880822,0.004437837,0.0006106803,0.0006968785,0.005095354,0.1209955,0.0002759175,0.00417974,0.2938682],"study_design_scores_gemma":[0.3430437,0.548168,0.08819105,0.00009408114,0.001070153,0.001650401,0.00009683525,0.002994752,0.00900317,0.000215583,0.005391814,0.00008038704],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995603,0.002754743,0.0002866446,0.0001466281,0.00002850356,0.0003231483,0.0003261537,0.00002968056,0.0005015469],"genre_scores_gemma":[0.9945703,0.001479062,0.001093691,0.0004399894,0.00008340798,0.0003276907,0.001393998,0.00001937662,0.0005925178],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002524445,"threshold_uncertainty_score":0.01335073,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02511711121625155,"score_gpt":0.3428742125230949,"score_spread":0.3177571013068433,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}